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Background. The ABCD2 score is now identified as a useful clinical prediction rule to determine the risk for stroke in the days
following brain ischemic attacks. Aim. The present study aimed to introduce a new scoring system named “ABCD2F” and compare
its value with the previous ABCD2 system to predict recurrent ischemic stroke within 90 days of the initial cerebrovascular accident
(CVA). Methods. 138 consecutive patients with the final diagnosis of ischemic CVA or TIAs who referred to emergency ward of
Rasoul-e-Akram general hospital in Tehran from September 2012 to December 2013 were eligible. By adding a new score in the
presence of atrial fibrillation to ABCD2 system, the new scoring system as ABCD2F was introduced and the risk stratification was
done again on this new system. Results. The area under the curve for ABCD2 was 0.434 and for ABCD2F it was 0.452 indicating
low value of both systems for assessing recurrence of stroke within 90 days of primary event. Multivariable logistic regression
analysis showed that none of the baseline factors could predict 90-day recurrent stroke.Conclusion. ABCD2 and/or atrial fibrillation
are not good scoring candidates for assessing the risk of recurrent stroke within first 90 days.
1. Introduction
Cerebrovascular events still remain as one of the major
leading causes of death and disability all over the world.
Only in the United States, the annual incidence of these
events has been estimated to be 780.000 strokes, 600.000 as
the primary strokes and others as recurrent attacks [1]. The
management of cerebrovascular disorders has imposed a high
cost on healthcare management systems with an estimation
of 65.5 billion dollars in the USA in 2008 [2]. Much of
this cost has been related to prevention and management
of recurrent stroke. Studies have given point estimation of
3-year stroke recurrence rates between 6% and 25% [3–5].
Incidence rates of first stroke recurrence were highest in the
first year after index stroke with a risk of 8.0% ranging from
3.5% to 1.8% within the second, third, fourth, and fifth years
[6]. Ever, some potential risk factors have been identified
to predispose patients to recurrent brain stroke including
residual extracranial and intracranial occlusive disease and
multiple and crescendo TIAs and hypertension (for early
stroke recurrence) and advanced age, hypertension, heart
disease, and diabetes mellitus (for late stroke recurrence)
[5, 7–9]. In this regard, the main principles for recurrence of
brain stroke include evaluation for risk factors and evaluation
for cause (arterial and cardiac abnormalities), as well as
management of the risk factors through lifestyle modifica-
tion, using proper medications and surgical or endovascular
interventions, if required. The first step for prognostic and
preventive management of recurrent brain stroke is risk
stratification of this event. Various scoring systems have
been employed to stratify the risk for this event so far. The
ABCD2 score is now identified as a useful clinical prediction
rule to determine the risk for stroke in the days following
primary brain ischemic attacks, particularly after TIAs [10].
This score has been structured based on five parameters
of age, clinical features, duration of TIA, blood pressure
measure, and diabetes mellitus that scores of each item are
added together to produce an overall result ranging between
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Table 1: Inclusion and exclusion criteria of study.
Inclusion criteria Exclusion criteria
(1) Patients with ischemic CVA
(2) Patients with TIA
(3) The complete presence of the
data of the patient
(1) Patients with hemorrhagic
stroke
(2) Death within the admission
period
(3) Death within 90 days of
discharge
(4) Lack of follow-up within 90
days of discharge
(5) Lack of enough follow-up
data
zero and seven [11]. The follow-up period for this score can
be either between 0 and 7 days of the cerebrovascular event
(acute phase) or between 8 and 90 days (subacute phase)
[12]. According to the risk stratification rule of this scoring
system, the risk for recurrent stroke within 2 to 7 days ranged
from 1.0% to 1.2% in the low-risk group, from 4.1% to 5.9%
in the moderate-risk group, and from 8.1% to 11.7% in the
high-risk group [12]. The expected 90-day risks of stroke in
these groups were 3.1%, 10%, and 17.4%, respectively [13].
Interestingly, the relevance of some other risk profiles such as
atrial fibrillationwith increased risk for recurrent brain stroke
has been proposed [14, 15], and thus it seems that adding
this factor to common scoring systems such as ABCD2 can
increase its prognostic value for these patients. The present
study aimed to add the presence of atrial fibrillation as a
potential risk factor to ABCD2 system and to modify it as a
new scoring systemnamed “ABCD2F.”Then, the value of this
new system was compared to the previous ABCD2 system
to predict recurrent brain stroke within 90 days of the initial
cerebrovascular accident.
2. Materials and Methods
In this study, 138 consecutive patients with the final diagnosis
of ischemic cerebrovascular accidents (CVA) or TIAs who
referred to emergency ward of Rasoul-e-Akram Hospital in
Tehran, Iran, from September 2012 to December 2013 were
eligible for the study. The patients with hemorrhagic CVA
or those who died within 90 days of discharge from the
hospital were excluded (Table 1). The primary information
of the patients was retrospectively collected by reviewing the
recorded hospital files and baseline characteristics, including
demographics, medical history, clinical findings, and also
laboratory and imaging parameters. With regard to assessing
the patients’ sequel, it was followed up by telephone in
order to assess the reappearance of the symptoms of CVA
or TIAs. Furthermore, if the patients referred to emergency
ward of the hospital within 90 days of primary admission,
the additional data were also collected by reviewing the
recorded files. The severity of stroke was assessed using the
NIHSS score; as the score of 0 indicated no stroke symptoms,
the score of 1–4 indicated minor stroke, the score of 5–
15 indicated moderate stroke, the score of 16–20 indicated
moderate-to-severe stroke, and the score of 21–42 indicated
severe stroke. Using the baseline information, the level of
risk for recurrent brain stroke was initially determined based
on the ABCD2 scoring system. Then, by adding a new score
for the presence of atrial fibrillation to ABCD2 system, the
new scoring system as “ABCD2F” was introduced and the
risk stratification was done again on this new system. The
study endpoint was to determine the value of ABCD2 and
ABCD2F systems to distinguish occurrence of the recurrent
brain stroke within 90 days of primary event and also to
determine the discriminative value across the two scoring
systems.
Resultswere presented asmean± standard deviation (SD)
for quantitative variables and were summarized by absolute
frequencies and percentages for categorical variables. Cat-
egorical variables were compared using Chi-square test or
Fisher’s exact test when more than 20% of cells with an
expected count of less than 5 were observed. Quantitative
variables were also compared with t-test or Mann-Whitney
U test. A receiver operating characteristic (ROC) curve
was used to determine the value of scoring systems to
distinguish occurring from nonoccurring recurrent stroke
and also to determine the sensitivity and specificity. For the
statistical analysis, the statistical software SPSS version 16.0
for Windows (SPSS Inc., Chicago, IL) was used. 𝑝 values of
0.05 or less were considered statistically significant.
3. Results
In total, 138 patients were included within the study with
the mean age of 65.48 ± 12.03 years (ranged from 35 to 88
years) and 64.5% of them were males. Regarding the type
of stroke, 76.8% had an ischemic stroke, and others suffered
from TIAs. In electrocardiographic assessment, 64.5% had
the normal pattern, while atrial fibrillation was revealed in
6.5%; furthermore, 13.0% had evidence of cardiac ischemic
events, and 5.1% had cardiac blocks. With regard to initial
symptoms on admission, 71.7% had weakness plus speech
abnormality, 12.3% had speech abnormality alone, and 15.9%
had symptoms related to posterior circulation. The duration
of symptoms in patients who suffered from TIA was less than
10 minutes in 4.3%, while the symptoms lasted more than 60
minutes in 11.6% of them. In total, only 3.6% were admit-
ted to ICUs on admission time. Regarding hemodynamic
indices, 52.9% had first systolic blood pressure higher than
120mmHg, 30.4% had first diastolic blood pressure higher
than 90mmHg, and 29.7% had first pulse rate higher than
90 beats per minute. Assessing cardiovascular risk factors
showed the history of CVA in 13.0%, history of TIAs in 1.4%,
history of ischemic heart disease in 24.6%, and history of
valvular heart disease in 5.8%.Also, previous atrial fibrillation
was found in 2.2%. Moreover, 28.3% were diabetic, 56.5%
were hypertensive, 15.2% were hyperlipidemic, and 23.2%
were smokers. With respect to oral medications, aspirin was
used in 26.1%, clopidogrel in 2.9%, and warfarin in 5.8%.
The mean ejection fraction of left ventricle was 50.46 ±
9.46 percent and, in 20.3% of cases, the ejection fraction
of left ventricle was less than 35%. Left heart clot was only
observed in 1.4% and left ventricle aneurism was observed in
4.3%, whereas wall motion abnormality in echocardiography
was found in 18.8%. The mean of total initial NIHSS was
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Table 2: Multivariate logistic regression analysis to determine predictors of recurrent brain stroke.
Variable 𝐵 Wald 𝑝 value OR 95% CI for OR
Lower Upper
Gender −0.368 0.121 0.728 0.692 0.087 5.507
Age 0.033 0.835 0.361 1.034 0.962 1.111
Type of stroke −0.128 0.054 0.815 0.880 0.300 2.579
NIHSS −0.025 0.077 0.781 0.975 0.817 1.165
CVA −0.746 0.301 0.583 0.474 0.033 6.805
IHD 0.559 0.342 0.559 1.749 0.269 11.397
DM 0.265 0.099 0.753 1.303 0.251 6.769
HTN −0.469 0.314 0.575 0.625 0.121 3.233
HLP −0.489 0.153 0.695 0.613 0.053 7.091
Smoking −0.840 0.443 0.506 0.432 0.036 5.121
EF −0.011 0.039 0.844 0.989 0.889 1.101
Discharge with ASA −0.364 0.059 0.809 0.695 0.036 13.287
Discharge with clopidogrel 1.654 1.003 0.317 5.226 0.205 132.960
Discharge with warfarin 0.192 0.012 0.911 1.212 0.041 35.563
WMA 0.309 0.069 0.792 1.362 0.137 13.563
LV aneurysm 1.062 0.349 0.555 2.891 0.085 97.966
Constant −3.577 0.501 0.479 0.028
Hosmer-Lemeshow goodness of fit: 𝜒2 = 20.650; 𝑝 = 0.008.
8.38 ± 5.26 and 1.06 ± 1.98 in patients with stroke and
TIA, respectively. Based on NIHSS, in patients with ischemic
stroke, 23.8%hadmild stroke, 61.9%had themoderate stroke,
13.3% had moderate-to-severe stroke, and only 1.0% had
severe stroke.
The follow-up of the patients for 90 days showed recur-
rent stroke, as TIAs or ischemic stroke was revealed in 9.4%.
No difference was found between the patients with and
without 90-day clinical recurrent stroke in bothABCD2 score
(4.62 ± 1.80 versus 5.06 ± 1.30; 𝑝 = 0.406) and ABCD2F
score (4.77 ± 1.96 versus 5.11 ± 1.31; 𝑝 = 0.395). In total,
a strong correlation was observed between the two scoring
systems (𝑟 = 0.984; 𝑝 < 0.001).
Using the ROC curve analysis for determining the value
of scoring systems to predict recurrent stroke, the area under
the curve for ABCD2 was 0.434 (95% CI: 0.245–0.623; 𝑝 =
0.433) and for ABCD2F it was 0.452 (95% CI: 0.256–0.648;
𝑝 = 0.567), indicating low value of both systems for assessing
recurrence of stroke within 90 days of the primary event
(Figure 1).
Multivariable logistic regression analysis (Table 2)
showed that none of the baseline factors could predict 90-
day recurrent stroke.
4. Discussion
The current study attempted to assess ABCD2 scoring system
of two aspects. First, we aimed to assess the value of this tool
to predict occurring recurrent brain stroke within 90 days
of first attacks. Second, we would like to examine whether
adding occurrence of atrial fibrillation to this scoring system
could enhance its value to predict recurrent brain stroke
ROC curve
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ABCD2
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Figure 1: Area under the ROC curve analysis to assess the value of
ABCD2 and ABCD2F tools to predict recurrent brain stroke.
within this follow-up time. In this regard, the study had some
important points. First, we showed that the ABCD2 scoring
system was not valuable enough for predicting 3-month
recurrent brain stroke. In other words, by using two statistical
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tools, includingmultivariable regressionmodeling and calcu-
lating area under the ROC curve, we could not demonstrate
its high power to distinguish recurrent stroke. As previously
noted, the ABCD2 scoring system was introduced to assess
the risk for recurrent stroke during the first week of initial
attack and thus its value to predict long-term stroke events
had been already questioned. According to our results, it
seems that the pure ABCD2 cannot be applied to assess mid-
term or long-term recurrent cerebrovascular events, at least
in our patients’ population. Second, we also showed that even
adding the parameter of atrial fibrillation could not improve
the predicting value of ABCD2. In total, the low power of
ABCD2 or its new version as ABCD2F can be explained by
some reasons. First, it seems that, for improving its predictive
value, we have to consider some other potential risk factors
for delayed recurrent brain stroke admission etiologic stroke
subtype, prior history of TIA/stroke, and topography, age,
and distribution of brain infarcts. As also shown by Ay et al.
[16], the new scoring system named RRE-90 including above
parameters demonstrated good predictive performance with
high reliability and also high external validity to predict 90-
day risk of recurrent stroke. Thus, assessing this new scoring
system among various populations such as our population
is recommended. Second, a wide spectrum of risk factors
has been identified as determinants for recurrent brain
stroke. In other words, the causes of recurrent stroke are
completely multifactorial. It has been indicated that diabetes
and atrial fibrillation are two potential risk factors for mid-
term recurrent attack of brain stroke [6]. Even the origin
of stroke can be a major factor. In total, the relationship
between risk factors such as ethnicity, diabetes mellitus,
hypertension, and atrial fibrillation and stroke recurrence
has been examined in several studies [3–6]. However, few
had sufficient sample sizes or used multivariable analysis to
control for confounding factors. Furthermore, no estimates
have been made of the proportion of stroke recurrences that
are attributable to these risk factors.
It should be noted that the risk factors for recurrence
of stroke may be more complex and confounding. One of
these major confounding factors is the type of the treatment
following first cerebrovascular accident. From this point of
view, the origin of stroke is very important and choosing of
the type of treatment depends on it. As noted before, atrial
fibrillation plays an important role in cardioembolic strokes.
Also, Ois et al. showed that severe symptomatic cerebral arte-
rial diseases have approximately five times risk for recurrence
of stroke within 90 days [17]. The mode of the treatment
in these conditions, including interventional procedures or
medical treatments, affects the outcome of event, particularly
recurrence of stroke. Inmultivariate analysis, surprisingly, we
found that discharge with clopidogrel increases the risk for
recurrent stroke by more than five times (OR = 5.23), but
discharge with ASA and warfarin has OR of 0.69 and OR of
1.21, respectively. The possible explanation for these results
can be the small number of patients who take clopidogrel (29
patients); however, a more detailed study is recommended to
clarify this challenge.
In conclusion, it seems that either ABCD2 scoring sys-
tem or ABCD2F scoring system cannot effectively predict
90-day recurrent brain stroke in our population. In other
words, ABCD2 and/or atrial fibrillation are not good scoring
candidates for assessing the risk of recurrent stroke within
first 90 days. In this regard, it is better to examine the value of
other confirmed scoring tools such as the RRE-90 system or
to discover other potential risk profiles to structure the new
scoring systems to predict recurrent brain stroke.
5. Conclusion
The ABCD2 and/or atrial fibrillation are not good scoring
candidates for assessing the risk of recurrent stroke within
first 90 days.
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